Lapatinib Terminated Phase 2 Trials for Cancer, Breast Treatment

TerminatedTreatment2 IdentifierTitleDrugs
NCT00657137APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)
NCT00756470Phase II Neoadjuvant in Inflammatory Breast Cancer
NCT00754702Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer
NCT00499681PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE